ArticleScientific reports2023

Re-irradiation combined with bevacizumab for recurrent glioblastoma beyond bevacizumab failure: survival outcomes and prognostic factors.

Weir-Chiang You et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.